首站-论文投稿智能助手
典型文献
Importation of SARS-CoV-2 Omicron variant in Beijing, China
文献摘要:
Omicron (B.1.1.529), the fifth variant of concern (VOC) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was firstly identified in November 2021 in South Africa. Omicron contains far more genome mutations than any other VOCs ever found, raising significant concerns about its increased transmissibility and immune evasion. Here, we report the importation of the Omicron variant into Beijing, China, in December 2021. Full-length genome sequences of five imported strains were obtained, with their genetic features characterized. Each strain contained 57 to 61 nucleotide substitutions, 39 deletions, and 9 insertions in the genome. Thirty to thirty-two amino acid changes were found in the spike proteins of the five strains. The phylogenetic tree constructed by the maximum likelihood method showed that all five imported genomes belonged to Omicron (BA.1) (alias of B.1.1.529.1), which is leading to the current surge of coronavirus disease 2019 (COVID-19) cases worldwide. The globally increased COVID-19 cases driven by the Omicron variant pose a significant challenge to disease prevention and control in China. Continuous viral genetic surveillance and increased testing among international travellers are required to contain this highly contagious variant.
文献关键词:
COVID-19;SARS-CoV-2;Omicron variant;Genomic characteristics
作者姓名:
Li Fu;Liang Zhichao;Cui Shujuan;Lv Bing;Feng Zhaomin;Xu Hui;Jia Lei;Yang Peng;Wang Quanyi;Pan Yang;Zhang Daitao
作者机构:
Beijing Center for Disease Prevention and Control, Beijing 100013, China
引用格式:
[1]Li Fu;Liang Zhichao;Cui Shujuan;Lv Bing;Feng Zhaomin;Xu Hui;Jia Lei;Yang Peng;Wang Quanyi;Pan Yang;Zhang Daitao-.Importation of SARS-CoV-2 Omicron variant in Beijing, China)[J].生物安全与健康 (英文),2022(03):150-153
A类:
Importation
B类:
SARS,CoV,Omicron,variant,Beijing,China,fifth,severe,acute,respiratory,syndrome,coronavirus,was,firstly,identified,November,South,Africa,contains,far,more,mutations,than,any,other,VOCs,found,raising,significant,concerns,about,its,increased,transmissibility,immune,evasion,Here,report,importation,into,December,Full,length,sequences,five,imported,strains,were,obtained,their,features,characterized,Each,contained,nucleotide,substitutions,deletions,insertions,Thirty,thirty,two,amino,acid,changes,spike,proteins,phylogenetic,tree,constructed,by,maximum,likelihood,method,showed,that,genomes,belonged,BA,alias,which,leading,current,surge,disease,cases,worldwide,globally,driven,pose,challenge,prevention,control,Continuous,viral,surveillance,testing,among,international,travellers,are,required,this,highly,contagious,Genomic,characteristics
AB值:
0.6397
相似文献
Common mtDNA variations at C5178a and A249d/T6392C/G10310A decrease the risk of severe COVID?19 in a Han Chinese population from Central China
Yi Wu;Xian‑Hui Wang;Xi‑Hua Li;Li‑Yuan Song;Shi‑Long Yu;Zhi‑Cheng Fang;Yu‑Quan Liu;Le‑Yong Yuan;Chun‑Yan Peng;Shen‑Yi Zhang;Wang Cheng;Hong‑Chao Ma;Li‑Feng Wang;Jun‑Ming Tang;Yun‑Fu Wang;Fu‑Yun Ji-Department of Medical Biology,School of Basic Medical Science,Hubei University of Medicine,Shiyan 442000,Hubei,China;Institute of Biomedical Research,Hubei University of Medicine,Shiyan 442000,Hubei,China;Institute of Human Respiratory Disease,Xinqiao Hospital,The Army Medical University(Third Military Medical University),400037 Chongqing,China;Department of Emergency Medicine,Taihe Hospital,Hubei University of Medicine,Shiyan 442000,Hubei,China;Department of Geriatric Medicine,Taihe Hospital,Hubei University of Medicine,Shiyan 442000,Hubei,China;Department of Immunology,School of Basic Medical Sciences,Hubei University of Medicine,Shiyan 442000,Hubei,China;Department of Laboratory Medicine,Taihe Hospital,Hubei University of Medicine,Shiyan 442000,Hubei,China;Hubei Key Laboratory of Embryonic Stem Cell Research,School of Basic Medical Science,Hubei University of Medicine,Shiyan 442000,Hubei,China;Department of Neurology,Taihe Hospital,Hubei University of Medicine,Shiyan 442000,Hubei,China
The rapid and efficient strategy for SARS-CoV-2 Omicron transmission control: analysis of outbreaks at the city level
Zheng Jin-Xin;Lv Shan;Tian Li-Guang;Guo Zhao-Yu;Zheng Pei-Yong;Chen Yue-Lai;Guan Shi-Yang;Wang Wei-Ming;Zhang Shun-Xian-Department of Nephrology, Ruijin Hospital, Institute of Nephrology, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, People’s Republic of China;Chinese Center for Disease Control and Prevention (Chinese Center for Tropical Diseases Research), NHC Key Laboratory of Parasite and Vector Biology, WHO Collaborating Centre for Tropical Diseases, National Center for International Research On Tropical Diseases, National Institute of Parasitic Diseases, Shanghai 200025, People’s Republic of China;Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200032, People’s Republic of China;Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, Hefei 230032, People’s Republic of China;School of Global Health, Chinese Center for Tropical Diseases Research, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, People’s Republic of China;One Health Center, Shanghai Jiao Tong University–The University of Edinburgh, Shanghai 200025, People’s Republic of China
A CRISPR/Cas12a-empowered surface plasmon resonance platform for rapid and specific diagnosis of the Omicron variant of SARS-CoV-2
Zhi Chen;Jingfeng Li;Tianzhong Li;Taojian Fan;Changle Meng;Chaozhou Li;Jianlong Kang;Luxiao Chai;Yabin Hao;Yuxuan Tangl;Omar A.Al-Hartomy;Swelm Wageh;Abdullah G.Al-Sehemi;Zhiguang Luo;Jiangtian Yu;Yonghong Shao;Defa Li;Shuai Feng;William J.Liu;Yaqing He;Xiaopeng Ma;Zhongjian Xie;Han Zhang-Shenzhen Engineering Laboratory of Phosphorene and Optoelectronics;International Collaborative Laboratory of 2D Materials for Optoelectronics Science and Technology of Ministry of Education;Shenzhen Institute of Translational Medicine;Department of Otolaryngology,Shenzhen Second People's Hospital;the First Affiliated Hospital;Institute of Microscale Optoelectronics,Shenzhen University,Shenzhen 518060,China;Shenzhen International Institute for Biomedical Research,Shenzhen 518116,China;Shenzhen Han's Tech Limited Company,Shenzhen 518000,China;Shenzhen Metasensing Tech Limited Company,Shenzhen 518000,China;Department of Physics,Faculty of Science,King Abdulaziz University,Jeddah 21589,Saudi Arabia;Research Center for Advanced Materials Science(RCAMS),King Khalid University,Abha 61413,Saudi Arabia;Department of Chemistry,College of Science,King Khalid University,Abha 61413,Saudi Arabia;Zhongmin(Shenzhen)Intelligent Ecology Co Ltd,Shenzhen 518055,China;Key Laboratory of Optoelectronic Devices and Systems of Ministry of Education and Guangdong Province,College of Physics and Optoelectronic Engineering,Shenzhen University,Shenzhen 518060,China;Department of Laboratory Medicine,Shenzhen Children's Hospital,Shenzhen 518038,China;Optoelectronics Research Center,School of Science,Minzu University of China,Beijing 100081,China;NHC Key Laboratory of Biosafety,National Institute for Viral Disease Control and Prevention,Chinese Center for Disease Control and Prevention,Beijing 102206,China;Research Unit of Adaptive Evolution and Control of Emerging Viruses,Chinese Academy of Medical Sciences,Beijing 102206,China;Institute of Pathogenic Organism,Shenzhen Center for Disease Control and Prevention,Shenzhen 518055,China;Respiratory Department,Shenzhen Children's Hospital,Shenzhen 518038,China;Institute of Pediatrics,Shenzhen Children's Hospital,Shenzhen 518038,China
Rapid development of an updated mRNA vaccine against the SARS-CoV-2 Omicron variant
Na-Na Zhang;Rong-Rong Zhang;Yi-Fei Zhang;Kai Ji;Xiao-Chuan Xiong;Qian-Shan Qin;Peng Gao;Xi-Shan Lu;Hang-Yu Zhou;Hai-Feng Song;Bo Ying;Cheng-Feng Qin-Department of Virology,State Key Laboratory of Pathogen and Biosecurity,Beijing Institute of Microbiology and Epidemiology,Academy of Military Medical Sciences,Beijing,China;School of Medicine,Tsinghua University,Beijing,China;Kunming University of Science and Technology,Kunming,Yunnan,China;Suzhou Abogen Biosciences Co.,Ltd.,Suzhou,Jiangsu,China;School of Life Sciences,Fujian Agriculture and Forestry University,Fuzhou,Fujian,China;Institute of Systems Medicine,Chinese Academy of Medical Sciences&Peking Union Medical College,Beijing,China;Research Unit of Discovery and Tracing of Natural Focus Diseases,Chinese Academy of Medical Sciences,Beijing,China
Structural insights into the SARS-CoV-2 Omicron RBD-ACE2 interaction
Jun Lan;Xinheng He;Yifei Ren;Ziyi Wang;Huan Zhou;Shilong Fan;Chenyou Zhu;Dongsheng Liu;Bin Shao;Tie-Yan Liu;Qisheng Wang;Linqi Zhang;Jiwan Ge;Tong Wang;Xinquan Wang-The Ministry of Education Key Laboratory of Protein Science,Beijing Advanced Innovation Center for Structural Biology,Beijing Frontier Research Center for Biological Structure,Collaborative Innovation Center for Biotherapy,School of Life Sciences,Tsinghua University,Beijing,China;Microsoft Research Asia,Beijing,China;Shanghai Synchrotron Radiation Facility,Shanghai Advanced Research Institute,Chinese Academy of Sciences,Shanghai,China;Department of Chemistry,Tsinghua University,Beijing,China;Center for Global Health and Infectious Diseases,Comprehensive AIDS Research Center,and Beijing Advanced Innovation Center for Structural Biology,School of Medicine,Tsinghua University,Beijing,China
Structural and biochemical mechanism for increased infectivity and immune evasion of Omicron BA.2 variant compared to BA.1 and their possible mouse origins
Youwei Xu;Canrong Wu;Xiaodan Cao;Chunyin Gu;Heng Liu;Mengting Jiang;Xiaoxi Wang;Qingning Yuan;Kai Wu;Jia Liu;Deyi Wang;Xianqing He;Xueping Wang;Su-Jun Deng;H.Eric Xu;Wanchao Yin-The CAS Key Laboratory of Receptor Research,Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Shanghai,China;Shanghai Jemincare Pharmaceuticals Co.,Ltd.,Shanghai,China;School of Chinese Materia Medica,Nanjing University of Chinese Medicine,Nanjing,Jiangsu,China;The Shanghai Advanced Electron Microscope Center,Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Shanghai,China;University of Chinese Academy of Sciences,Beijing,China;School of Life Science and Technology,ShanghaiTech University,Shanghai,China;Zhongshan Institute for Drug Discovery,Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Guangdong,China
A broadly neutralizing antibody against SARS-CoV-2 Omicron variant infection exhibiting a novel trimer dimer conformation in spike protein binding
Yingdan Wang;Wuqiang Zhan;Jiangyan Liu;Yanqun Wang;Xiang Zhang;Meng Zhang;Lin Han;Yunping Ma;Lu Lu;Yumei Wen;Zhenguo Chen;Jincun Zhao;Fan Wu;Lei Sun;Jinghe Huang-Key Laboratory of Medical Molecular Virology(MOE/NHC/CAMS)and Shanghai Institute of Infectious Disease and Biosecurity,Shanghai Fifth People's Hospital,Shanghai Public Health Clinical Center,Institutes of Biomedical Sciences,School of Basic Medical Sciences,Fudan University,Shanghai,China;Shanghai Immune Therapy Institute,Shanghai Jiao Tong University School of Medicine Affiliated Renji Hospital,Shanghai,China;State Key Laboratory of Respiratory Disease,National Clinical Research Center for Respiratory Disease,Guangzhou Institute of Respiratory Health,the First Affiliated Hospital of Guangzhou Medical University,Guangzhou,Guangdong,China;Institute of Infectious Disease,Guangzhou Eighth People's Hospital of Guangzhou Medical University,Guangzhou,Guangdong,China
Omicron-specific mRNA vaccine elicits potent immune responses in mice,hamsters,and nonhuman primates
Yi Wu;Yanqiong Shen;Namei Wu;Xinghai Zhang;Shaohong Chen;Chang Yang;Junhui Zhou;Yan Wu;Da Chen;Li Wang;Chao Wang;Huajun Zhang;Ninuo Xia;Sandra Chiu;Yucai Wang-Department of Radiology,The First Affiliated Hospital of USTC,Division of Life Sciences and Medicine,University of Science and Technology of China,Hefei,Anhui,China;School of Basic Medical Sciences,Division of Life Sciences and Medicine,University of Science and Technology of China,Hefei,Anhui China;State Key Laboratory of Virology,Wuhan Institute of Virology,Center for Biosafety Mega-Science,Chinese Academy of Sciences,Wuhan,Hubei,China;University of Chinese Academy of Sciences,Beijing,China;MOE Key Laboratory for Cellular Dynamics,Division of Life Sciences and Medicine,University of Science and Technology of China,Hefei,Anhui,China;RNAIfa Biotech,Hefei,Anhui,China
Molecular analysis of Coxsackievirus A24 variant isolates from three outbreaks of acute hemorrhagic conjunctivitis in 1988,1994 and 2007 in Beijing,China
Junhan Li;Fang Huang;Yong Zhang;Tianjiao Ji;Shuangli Zhu;Dongyan Wang;Zhenzhi Han;Jinbo Xiao;Fenfen Si;Wenbo Xu;Dongmei Yan-National Polio Laboratory,WHO WPRO Regional Polio Reference Laboratory,National Health Commission Key Laboratory for Biosecurity,National Health Commission Key Laboratory for Medical Virology,National Institute for Viral Disease Control and Prevention,Chinese Center for Disease Control and Prevention,Beijing,102206,China;Nanguan District Center for Disease Control and Prevention,Changchun,130042,China;Beijing Center for Disease Control and Prevention,Beijing,100000,China;Center for Biosafety Mega-Science,Chinese Academy of Sciences,Wuhan,430000,China
Comparison of viral propagation and drug response among SARS-CoV-2 VOCs using replicons capable of recapitulating virion assembly and release
Lingqian Tian;Qiuhong Liu;Rongjuan Pei;Yingshan Chen;Chonghui Xu;Jielin Tang;Hao Sun;Kunpeng Liu;Qi Yang;Lei Yang;Leshan Li;Yongli Zhang;Yuan Zhou;Chao Shan;Xue Hu;Xinwen Chen;Yun Wang-State Key Laboratory of Virology,Wuhan Institute of Virology,Center for Biosafety Mega-Science,Chinese Academy of Sciences,Wuhan,430071,China;University of Chinese Academy of Sciences,Beijing 100049,China;Guangzhou Institutes of Biomedicine and Health,Chinese Academy of Sciences,Guangzhou,510530,China;Department of Gastroenterology,Guangzhou Women and Children's Medical Center,Guangzhou,510623,China;Innovation Center for Pathogen Research,Guangzhou Laboratory,Guangzhou,510320,China
Characteristics of replication and pathogenicity of SARS-CoV-2 Alpha and Delta isolates
Xiao-Li Feng;Dandan Yu;Mi Zhang;Xiaohong Li;Qing-Cui Zou;Wentai Ma;Jian-Bao Han;Ling Xu;Cuixian Yang;Wang Qu;Zhong-Hua Deng;Junyi Long;Yanghaopeng Long;Mingkun Li;Yong-Gang Yao;Xing-Qi Dong;Jianxiong Zeng;Ming-Hua Li-Kunming National High-level Biosafety Research Center for Non-Human Primates,Center for Biosafety Mega-Science,Kunming Institute of Zoology,Chinese Academy of Sciences,Kunming,650107,China;Key Laboratory of Animal Models and Human Disease Mechanisms of the Chinese Academy of Sciences,and KIZ-CUHK Joint Laboratory of Bioresources and Molecular Research in Common Diseases,Kunming Institute of Zoology,Chinese Academy of Sciences,Kunming,650201,China;National Resource Center for Non-Human Primates,National Research Facility for Phenotypic&Genetic Analysis of Model Animals(Primate Facility),Kunming Institute of Zoology,Chinese Academy of Sciences,Kunming 650107,China;Department of Infectious Diseases,Yunnan Provincial Infectious Diseases Hospital,Kunming,650301,China;Key Laboratory of Genomic and Precision Medicine,Beijing Institute of Genomics,Chinese Academy of Sciences,and China National Center for Bioinformation,Beijing,100101,China;University of Chinese Academy of Sciences,Beijing,100049,China;Center for Excellence in Animal Evolution and Genetics,Chinese Academy of Sciences,Kunming,650201,China;Kunming College of Life Science,University of Chinese Academy of Sciences,Kunming 650204,China;Yunnan Key Laboratory of Biodiversity Information,Kunming Institute of Zoology,Chinese Academy of Sciences,Kunming,650201,China
Neutralization of five SARS-CoV-2 variants of concern by convalescent and BBIBP-CorV vaccinee serum
Yuqi Zhu;Xinyi Yang;Jingna Xun;Jun Liu;Qing Wen;Yixiao Lin;Xiaoting Shen;Jun Chen;Songhua Yuan;Xiaying Zhao;Jing Wang;Hanyu Pan;Jinlong Yang;Zhiming Liang;Yue Liang;Qinru Lin;Huitong Liang;Min Li;Jianping Liu;Yinzhong Shen;Xiaoyan Zhang;Pengfei Wang;Daru Lu;Chunhua Yin;Jianqing Xu;Shibo Jiang;Hongzhou Lu;Huanzhang Zhu-State Key Laboratory of Genetic Engineering and Engineering Research Center of Gene Technology,Ministry of Education,Institute of Genetics,School of Life Sciences,Fudan University,Shanghai,200438,China;Scientific Research Center,Shanghai Public Health Clinical Center,Fudan University,Shanghai,201508,China;Fubio(Suzhou)Biomedical Technology Co.,Ltd,Suzou,215300,China;Department of Infectious Diseases and Immunology,Shanghai Public Health Clinical Center,Fudan University,Shanghai,201508,China;Key Laboratory of Medical Molecular Virology(MOE/NHC/CAMS),School of Basic Medical Sciences,Fudan University,Shanghai,200032,China;Department of Infectious Diseases and Nursing Research Institution,National Clinical Research Center for Infectious Diseases,The Third People's Hospital of Shenzhen,Shenzhen,518112,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。